Cancer Knowledge

In addition to serving as Editor-In-Chief for CollabRx, Dr. Lundberg is President and Chair of the Board of Directors of The Lundberg Institute, a Consulting Professor at Stanford University, and Editor at Large for Medscape from WebMD. Dr. Lundberg has more than 30 years combined experience as Editor in Chief of JAMA (The Journal of the American Medical Association), the 10 AMA specialty journals, AM News, Medscape, The Medscape Journal, e-Medicine from Web MD, and MedPage Today from Everyday Health. A frequent lecturer, radio and television guest, and a member of the Institute of Medicine of the National Academy of Sciences, the Industry Standard dubbed Dr. Lundberg “Online Healthcare’s Medicine Man” in 2000. Prior to CollabRx, Dr. Lundberg served as the President of the American Society for Clinical Pathology, Professor of Pathology and Associate Director of Laboratories at the Los Angeles County/USC Medical Center for 10 years, and for 5 years was the Professor and Chair of Pathology at the University of California, Davis. He served in the US Army during the Vietnam War, leaving as a lieutenant colonel after 11 years. Prior to his military service , Dr. Lundberg completed a clinical internship in Hawaii and a pathology residency in San Antonio. Called the medical Internet “pioneer” in 1995, Dr. Lundberg holds earned and honorary degrees from North Park College, Baylor University, the University of Alabama (Birmingham and Tuscaloosa), the State University of New York, Syracuse, Thomas Jefferson University and the Medical College of Ohio. Dr. Lundberg has worked in tropical medicine in Central America and Forensic Medicine in New York, Sweden, and England. His major professional interests are toxicology, violence, communication, physician behavior, patient safety, and health system reform.

Dr. Smruti Vidwans is an award-winning researcher and biomedical industry expert who has developed strategies for organizations ranging from pharma giants to drug-discovery startups and nonprofits. At CollabRx, she has driven the development of the molecular disease models, the proprietary Therapy Finder applications in cancers such as melanoma, lung cancer and colorectal cancer as well as the Genetic Variant Annotation product that provides therapeutic interpretation of NGS-derived molecular data. Prior to CollabRx, she was at McKinsey and Company where she worked on a developing a range of business and scientific solutions for the pharmaceutical industry – including clinical trial design and evaluation, R&D process optimization, business strategy implementation, and change management. She has co-founded and consulted with several drug discovery startups. In addition, she has worked in the Tuberculosis drug discovery space for which she was named one of the top 100 young investigators under 35. Dr. Smruti Vidwans holds a SB in Biology from the Massachusetts Institute of Technology, and a PhD in Genetics, Developmental and Molecular Biology from the University of California, San Francisco.

Clifford Baron has led product development, strategy and go to market efforts in prominent life science companies for over 20 years.  Prior to joining CollabRX, he was Director of Biology Product Marketing, Director of Business Development and Director of Professional Services at Accelrys.  He founded Lexigraphix, developing an innovative web-based system to analyze biotechnology intellectual property assets. Prior to that, Clifford was Senior Director of Global Solutions for Applied Biosystems, where he led software product management and coordinated Applied Biosystems’ alliance with Celera during the human genome project. He was Director of Product Management at Pangea Systems/Doubletwist, a pioneering bioinformatics company, and Vice President of Product Development for Abacus Concepts, a statistical software company acquired by SAS Corp. Clifford holds a Ph.D. in Biology from UC Berkeley.

Adrienne Craig-Kennard has over 15 years of international experience in executive leadership, business development, and research in the healthcare industry. Prior to joining CollabRx, Ms. Craig Kennard was Vice President of Global Clinical Informatics Sales at Strand Life Sciences. She led global go-to-market strategy and sales of Strand's NGS-based clinical diagnostics solutions to hospitals and healthcare systems in the US and Europe. As Vice President, European Sales at Ariana Pharma, Ms. Craig-Kennard led sales of the company’s clinical and biomarker data analytics services to pharmaceutical, diagnostics and healthcare organizations.  Ms. Craig-Kennard also served as Chief Operating Officer of two genomics companies: Genostar and NyxBio.  She developed strategies that resulted in growth across multiple market sectors, led business operations and sales, and negotiated and managed key industrial and academic partnerships. Earlier in her career, she held research and development roles at Abbott Laboratories, Wesley Jessen, and Chevron Chemical. Ms. Craig-Kennard holds a Bachelor of Science degree in Chemistry from the University of California, Berkeley, and a Master of Business Administration with honors from the Grenoble École de Management’s Grenoble Graduate School of Business.

Paul is a Silicon Valley startup veteran of 20 years, helping several small companies to develop their software and grow to acquisition by Cisco, Yahoo, Ask.com, Computer Sciences Corporation, and others. At CollabRx, he has helped lead the development team to get the product ready for commercial success, implementing production-quality availability, job automation, and data security. He leads the efforts to hire top-notch software talent while still contributing regularly to keep our systems running smoothly. Paul holds a BS in Computer Science from the Rensselaer Polytechnic Institute (RPI) in Troy, New York.

Michelle Turski, PhD is an expert in molecular oncology and genetics. Prior to CollabRx, she did her post-doctoral research on SIRT family genes that regulate stress resistance and lifespan in the Chua lab at Stanford.  She did her thesis work on roles for copper metabolism in cell proliferation, signaling, and disease in the Thiele lab at Duke University. At CollabRx she developed the Colorectal Cancer Therapy Finder web-based expert-system applications designed to inform physicians and patients about tumor molecular analysis and personalized treatment options for advanced cancers. Additionally she led the development of of the Genetic Variant Annotation (GVA) Service and also provides customer support for the GVA.

Lisandra West is a cell and molecular biologist who specializes in the development of technologies that enable making scientific or medical knowledge accessible.  At CollabRx she developed the Lung Cancer Therapy Finder and Breast Cancer Therapy Finder - Patient - web-based expert-system applications designed to inform physicians and patients about tumor molecular analysis and personalized treatment options for advanced cancers.  She went on to manage the suite of Therapy Finder products and expanded the product line to include Therapy Finders for additional cancers. She also developed CancerRx, a mobile version of Therapy Finder.  Additionally she has been a contributor to development of the Genetic Variant Annotation (GVA) Service and has provided internal product management for the GVA product.  Prior to CollabRx, she did her thesis work on the regulation of p53 function by lysine methylation in Or Gozani’s lab at Stanford. Lisandra holds a BS in Biology from Santa Clara University, and an MS and PhD in Cell and Molecular Biology from Stanford.  She is additionally a certified product manager, Pragmatic Marketing Certified - Level III (PMC-III).

Helen Sadik, PhD has extensive experience in molecular, genetic, and correlative oncology and in the scientific support of the development of different laboratory, pharmaceutical and clinical projects. At CollabRx, she is a Science Knowledge Engineer involved in the incorporation of relevant scientific updates into the knowledge database (the Genetic Variant Annotation, GVA) and in coordinating with product releases to ensure functionality. She is also engaged in developing the clinical trial database in GVA and in the support of CollabRx customers. Prior to CollabRx, she was a clinical research Fellow at Johns Hopkins Breast cancer center, where she developed new approaches for recruiting patients into clinical trials by acting as a research liaison between the research and the clinical team. She was also involved in preparing regulatory documents needed for initiating investigator- and sponsor- led clinical trials. Helen has graduated as valedictorian with a BS in Biology from the Lebanese American University and has received her PhD from John Hopkins University in breast cancer chemotherapy resistance.

Vivian Douglas is an molecular biologist with experience in a broad range of disease areas, including oncology, Type 2 diabetes, and infectious diseases. At CollabRx,Vivian is part of the Scientific Knowledge Engineering team researching scientific databases in order to incorporate actionable information into the CollabRx knowledgebase. Prior to joining CollabRx, she worked at N-of-One as part of the scientific research team and was also responsible for database content review. Her PhD thesis work focus on the genetic basis of resistance to infectious diseases and mechanisms of tissue colonization by Lyme disease spirochetes. Vivian holds a BA in French Literature from the University of California, San Diego and a PhD from the University of Massachusetts Medical School.